Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 16
Original Research
Rehmannioside A Inhibits TRAF6/MAPK Pathway and Improves Psoriasis by Interfering with the Interaction of HaCaT Cells with IL-17A
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
1,753 | Dovepress* | 1,576+ | 42 | 1,618 | |
PubMed Central* | 177 | 64 | 241 | ||
Totals | 1,753 | 106 | 1,859 | ||
*Since 21 September 2023 |
View citations on PubMed Central and Google Scholar